Correlation Between Panbela Therapeutics and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Panbela Therapeutics and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Panbela Therapeutics and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Panbela Therapeutics and CytomX Therapeutics, you can compare the effects of market volatilities on Panbela Therapeutics and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Panbela Therapeutics with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Panbela Therapeutics and CytomX Therapeutics.
Diversification Opportunities for Panbela Therapeutics and CytomX Therapeutics
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Panbela and CytomX is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Panbela Therapeutics and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Panbela Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Panbela Therapeutics are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Panbela Therapeutics i.e., Panbela Therapeutics and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Panbela Therapeutics and CytomX Therapeutics
If you would invest 206.00 in Panbela Therapeutics on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Panbela Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 1.56% |
Values | Daily Returns |
Panbela Therapeutics vs. CytomX Therapeutics
Performance |
Timeline |
Panbela Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
CytomX Therapeutics |
Panbela Therapeutics and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Panbela Therapeutics and CytomX Therapeutics
The main advantage of trading using opposite Panbela Therapeutics and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Panbela Therapeutics position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.Panbela Therapeutics vs. ZyVersa Therapeutics | Panbela Therapeutics vs. Sonnet Biotherapeutics Holdings | Panbela Therapeutics vs. Revelation Biosciences | Panbela Therapeutics vs. Altamira Therapeutics |
CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |